Developer docs
API playgroundTry for free, no card

Search company profiles

Proterro

Full company profile

uuid0007u4s

Namestring
Proterro
Legal namestring
Proterro
Websiteurl
proterro.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Proterro is a private biotechnology company founded in 2008 and headquartered in Ewing, United States, that develops a patented two-step technology platform for converting waste CO2 into high-value sugars and nutritional products using genetically modified cyanobacteria. The platform operates in two stages: first, cyanobacteria are modified to produce molecules designed to a partner's specifications; second, those organisms are cultivated at high yield in a proprietary solid state bioreactor that enables cleaner harvesting and flexible back-end integration. The system is modular and can be deployed indoors, in open fields, or in greenhouses, allowing it to scale with partner growth and co-locate with industrial CO2 sources. Proterro has secured two granted patents covering the Two-Step Technology Platform and the Fully Integrated Production System.

The company commercializes exclusively through licensing agreements with industry partners rather than selling finished products directly. Its stated target customers are market leaders across three verticals — Food, Animal Feed, and Energy — with two branded product categories (Proterro Sugars and Proterro Nutritionals) developed under bespoke specifications and purity standards. Proterro has raised a single disclosed round of $3.5M in December 2012 led by Braemar Energy Ventures, with co-investors Battelle Ventures, Cultivian Ventures, Innovation Valley Partners, and Middleland Capital. Leadership consists of Founder and Co-CEO Kef Kasdin (also a board member) and Chief Business Development Officer David Austgen, supported by a team of 51-100 employees.

The company positions its value proposition around price stability, reliable supply, and customizable molecule design in industries traditionally dependent on crop-derived sucrose and feed inputs, with the environmental benefit of waste CO2 utilization as a secondary narrative. However, the available evidence — including a last-updated web footprint from 2019 and the absence of any disclosed customers, partnerships, or subsequent funding — indicates that commercial traction has not been publicly validated, making the company difficult to benchmark against operating peers.

Short descriptiontext

Proterro is a private biotech company that licenses a patented cyanobacteria-based platform to convert waste CO2 into customized sugars and nutritional products for partners in the food, feed, and energy industries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPrinceton, United States
HQ citystring
Princeton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cyanobacteria biotechnology, biofeedstock production, sucrose manufacturing, CO2 conversion platform, algae-based bioproducts
Industry1 code
PRIMARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code2 codes
  • Other Basic Organic Chemical Manufacturing32519
  • Sugar Manufacturing31131
SIC code1 code
  • Sugar & Confectionery Products2060
Product category
Industrial Biotechnology
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Licensing Agreements
TypeLicensing Royalties
Description

Proterro generates revenue through license agreements with partners in the Food, Feed, and Energy industries. Partners pay for access to the company's patented technology platform and intellectual property to develop customized products.

proterro.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Proterro operates a patented two-step biotechnology platform that uses genetically modified cyanobacteria to convert waste CO2 into high-value products. The company produces sugars and nutritionals in a unique solid state bioreactor system and delivers these capabilities to industrial partners in the food, animal feed, and energy industries under licensing agreements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduced environmental impact through waste CO2 utilization
+3 more records
Product overview1 text field

Proterro is a biotechnology company offering a patented two-step technology platform that converts waste CO2 into high-value products using modified cyanobacteria. The platform includes two primary product categories: Proterro Sugars and Proterro Nutritionals. Products are developed under license agreements with partners in the global food, feed, and energy industries. The production process involves modifying cyanobacteria to produce molecules to partner specifications, then efficiently producing high-yield organisms in a unique solid state bioreactor system.

Product and service1 record
1Proterro Sugars
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
1Joule Unlimited (Arctus)
TypeDirect peer
Description

Cyanobacteria-based fuels and chemicals company (successor to Joule Unlimited). Directly comparable to Proterro on organism choice (cyanobacteria), target molecules (sugars/hydrocarbons for fuel and feed), and the well-documented challenges of cyanobacterial scale-up.

TypeBroad incumbent
Description

Global starch, polyol, and bio-based ingredient manufacturer serving food, feed, and pharma. Comparable to Proterro as a large incumbent in the sugar/starch-derived ingredients space Proterro aims to disrupt.

TypeBroad incumbent
Description

Plant-based and specialty ingredient company serving food and beverage with non-GMO, organic, and plant-based ingredients. Comparable to Proterro in addressing food and feed customers seeking sustainable, non-commodity ingredient alternatives.

TypeDirect peer
Description

Gas fermentation company using engineered microbes to convert waste CO/CO2 into fuels and chemicals, licensing its technology to industrial partners. Highly comparable to Proterro in waste-gas-to-product biology, licensing GTM, and energy/fuel end-markets.

TypeEmerging player
Description

Cyanobacteria-based fuel and chemical production company. Comparable to Proterro in organism platform, CO2-to-product biology, and the commercial challenges of scaling cyanobacterial production.

6Solazyme / TerVia (Corbion)
TypeDirect peer
Description

Algae-based oils and ingredients company, now part of Corbion's TerVia algae ingredients platform. Comparable to Proterro in using photosynthetic microorganisms to produce food/feed ingredients and in the licensing/partnering commercialization model.

7Synthetic Genomics
TypeEmerging player
Description

Synthetic biology and algae-based production company developing microbe-derived fuels, nutritionals, and aquaculture feeds. Comparable to Proterro in platform biology and the food/feed/energy application stack.

TypeDirect peer
Description

Synthetic biology company engineering microorganisms to produce bio-based ingredients (sugars, oils, specialty chemicals) under a licensing and partnership model. Most directly comparable to Proterro as a microbe-to-product biotech with multi-vertical end-market reach in food, feed, and personal care.

TypeBroad incumbent
Description

Global food ingredients company specializing in sweeteners, texturants, and sucralose. Comparable to Proterro as a major incumbent in industrial sweetener and food ingredient markets.

TypeEmerging player
Description

Synthetic biology company engineering microbial strains for food, feed, personal care, and pharma ingredients. Comparable to Proterro as a microbe-based B2B ingredients platform targeting similar end markets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Proterro

Industrial Biotechnologyproterro.com

Proterro is a private biotech company that licenses a patented cyanobacteria-based platform to convert waste CO2 into customized sugars and nutritional products for partners in the food, feed, and energy industries.

What Proterro does

Proterro is a private biotechnology company founded in 2008 and headquartered in Ewing, United States, that develops a patented two-step technology platform for converting waste CO2 into high-value sugars and nutritional products using genetically modified cyanobacteria. The platform operates in two stages: first, cyanobacteria are modified to produce molecules designed to a partner's specifications; second, those organisms are cultivated at high yield in a proprietary solid state bioreactor that enables cleaner harvesting and flexible back-end integration. The system is modular and can be deployed indoors, in open fields, or in greenhouses, allowing it to scale with partner growth and co-locate with industrial CO2 sources. Proterro has secured two granted patents covering the Two-Step Technology Platform and the Fully Integrated Production System.

The company commercializes exclusively through licensing agreements with industry partners rather than selling finished products directly. Its stated target customers are market leaders across three verticals — Food, Animal Feed, and Energy — with two branded product categories (Proterro Sugars and Proterro Nutritionals) developed under bespoke specifications and purity standards. Proterro has raised a single disclosed round of $3.5M in December 2012 led by Braemar Energy Ventures, with co-investors Battelle Ventures, Cultivian Ventures, Innovation Valley Partners, and Middleland Capital. Leadership consists of Founder and Co-CEO Kef Kasdin (also a board member) and Chief Business Development Officer David Austgen, supported by a team of 51-100 employees.

The company positions its value proposition around price stability, reliable supply, and customizable molecule design in industries traditionally dependent on crop-derived sucrose and feed inputs, with the environmental benefit of waste CO2 utilization as a secondary narrative. However, the available evidence — including a last-updated web footprint from 2019 and the absence of any disclosed customers, partnerships, or subsequent funding — indicates that commercial traction has not been publicly validated, making the company difficult to benchmark against operating peers.

Proterro firmographics

Firmographics
Name
Proterro
Legal name
Proterro
Website
https://proterro.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
1–10 employees
Short description
Proterro is a private biotech company that licenses a patented cyanobacteria-based platform to convert waste CO2 into customized sugars and nutritional products for partners in the food, feed, and energy industries.
Ownership category
akta.pro rank

Proterro industry classification

Industry
Product category
Industrial Biotechnology
NAICS
Other Basic Organic Chemical Manufacturing (32519), Sugar Manufacturing (31131)
SIC
Sugar & Confectionery Products (2060)
akta.pro industry
PRIMARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Cyanobacteria biotechnology
  • Biofeedstock production
  • Sucrose manufacturing
  • CO2 conversion platform
  • Algae-based bioproducts

Where Proterro is headquartered

Location

Headquarters

HQ city
Princeton
HQ country
United States
HQ region
North America

Markets served

Proterro business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain

Revenue model

  1. Licensing Agreements: Proterro generates revenue through license agreements with partners in the Food, Feed, and Energy industries. Partners pay for access to the company's patented technology platform and intellectual property to develop customized products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Proterro product offering

Product offering

Core offering

Proterro operates a patented two-step biotechnology platform that uses genetically modified cyanobacteria to convert waste CO2 into high-value products. The company produces sugars and nutritionals in a unique solid state bioreactor system and delivers these capabilities to industrial partners in the food, animal feed, and energy industries under licensing agreements.

Product overview

Proterro is a biotechnology company offering a patented two-step technology platform that converts waste CO2 into high-value products using modified cyanobacteria. The platform includes two primary product categories: Proterro Sugars and Proterro Nutritionals. Products are developed under license agreements with partners in the global food, feed, and energy industries. The production process involves modifying cyanobacteria to produce molecules to partner specifications, then efficiently producing high-yield organisms in a unique solid state bioreactor system.

Differentiator

Problem solved

Functional benefit

Products and services

  • Proterro Sugars

Quantifiable outcome

  • Reduced environmental impact through waste CO2 utilization
  • +3 more outcomes

Companies that use Proterro

Customer profile

Segments5 records

Ideal customer profiles3 records

Proterro technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Proterro partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights2 records

Proterro competitors and assessment

Company assessment

Direct peers

  • Joule Unlimited (Arctus): Cyanobacteria-based fuels and chemicals company (successor to Joule Unlimited). Directly comparable to Proterro on organism choice (cyanobacteria), target molecules (sugars/hydrocarbons for fuel and feed), and the well-documented challenges of cyanobacterial scale-up.
  • LanzaTech: Gas fermentation company using engineered microbes to convert waste CO/CO2 into fuels and chemicals, licensing its technology to industrial partners. Highly comparable to Proterro in waste-gas-to-product biology, licensing GTM, and energy/fuel end-markets.
  • Solazyme / TerVia (Corbion): Algae-based oils and ingredients company, now part of Corbion's TerVia algae ingredients platform. Comparable to Proterro in using photosynthetic microorganisms to produce food/feed ingredients and in the licensing/partnering commercialization model.
  • Amyris: Synthetic biology company engineering microorganisms to produce bio-based ingredients (sugars, oils, specialty chemicals) under a licensing and partnership model. Most directly comparable to Proterro as a microbe-to-product biotech with multi-vertical end-market reach in food, feed, and personal care.

Broad incumbents

  • Roquette: Global starch, polyol, and bio-based ingredient manufacturer serving food, feed, and pharma. Comparable to Proterro as a large incumbent in the sugar/starch-derived ingredients space Proterro aims to disrupt.
  • SunOpta: Plant-based and specialty ingredient company serving food and beverage with non-GMO, organic, and plant-based ingredients. Comparable to Proterro in addressing food and feed customers seeking sustainable, non-commodity ingredient alternatives.
  • Tate & Lyle: Global food ingredients company specializing in sweeteners, texturants, and sucralose. Comparable to Proterro as a major incumbent in industrial sweetener and food ingredient markets.

Emerging players

  • Algenol: Cyanobacteria-based fuel and chemical production company. Comparable to Proterro in organism platform, CO2-to-product biology, and the commercial challenges of scaling cyanobacterial production.
  • Synthetic Genomics: Synthetic biology and algae-based production company developing microbe-derived fuels, nutritionals, and aquaculture feeds. Comparable to Proterro in platform biology and the food/feed/energy application stack.
  • Bota Bio: Synthetic biology company engineering microbial strains for food, feed, personal care, and pharma ingredients. Comparable to Proterro as a microbe-based B2B ingredients platform targeting similar end markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Proterro social profiles

Digital presence

Proterro financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Proterro leadership team

Management profile

Number of profiles

Profiles2 records

Proterro funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Proterro M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Proterro

What does Proterro do?

Proterro operates a patented two-step biotechnology platform that uses genetically modified cyanobacteria to convert waste CO2 into high-value products. The company produces sugars and nutritionals in a unique solid state bioreactor system and delivers these capabilities to industrial partners in the food, animal feed, and energy industries under licensing agreements.

Is Proterro a public or private company?

Proterro is a private company. It is classified as venture growth investor backed and is currently operating.

When was Proterro founded?

Proterro was founded in 2008. It employs 1 to 10 people.

Where is Proterro based?

Proterro is headquartered in Princeton, United States, in the North America region.

How does Proterro make money?

One revenue line is on record: licensing Agreements.

Who are Proterro's main competitors?

Direct peers on record are Joule Unlimited (Arctus), LanzaTech, Solazyme / TerVia (Corbion) and Amyris. Broad incumbents are Roquette, SunOpta and Tate & Lyle. Emerging players are Algenol, Synthetic Genomics and Bota Bio.

Does Proterro have an API?

No public API is recorded for Proterro.

What industry is Proterro in?

Proterro's product category is Industrial Biotechnology. Its primary akta.pro industry code is EUAAAIAA, Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol). Its NAICS code is 32519 and its SIC code is 2060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals